FDA Inspection 1330534 — Galentic Pharma (India) Pvt. Ltd

Galentic Pharma (India) Pvt. Ltd — FEI 3012178852

The FDA completed an inspection of Galentic Pharma (India) Pvt. Ltd on Aug 11, 2026 in Gandhidham. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 11, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Gandhidham (India)

Citations

IDCFRDescription
145121 CFR 211.113(b)Procedures for sterile drug products
145221 CFR 211.113(b)Validation lacking for sterile drug products
188321 CFR 211.165(a)Testing and release for distribution

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.